Drug intelligence / Profile preview

modified triple antibiotic paste

Development stage
Unknown
Lead developer
Tanta University
Modality
Small Molecules
Administration
Topical
01

Overview

Modified triple antibiotic paste (MTAP) is a combination antimicrobial formulation used as an intracanal medicament in endodontic therapy, specifically for treating secondary endodontic infections and in regenerative procedures. Developed and evaluated by researchers at Tanta University, this specific formulation is modified typically by replacing minocycline with another antibiotic (such as clindamycin or cefaclor) to prevent the tooth discoloration associated with traditional triple antibiotic paste (TAP). The paste typically contains metronidazole, ciprofloxacin, and a third antibiotic, which work synergistically to eradicate persistent intracanal pathogens, most notably *Enterococcus faecalis*. Metronidazole provides activity against anaerobic bacteria, ciprofloxacin offers broad-spectrum gram-negative coverage, and the third agent targets gram-positive organisms.

Other names
MTAPmodified triple antibiotic paste-Tanta University
02

Targets

Bacterial 50S ribosomal subunitBacterial RibosomePBP (Penicillin-binding protein family)NeuraminidaseDNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on modified triple antibiotic paste.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on modified triple antibiotic paste.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call